On 2025-05-15, MiNK Therapeutics, Inc. (INKT) announced earnings per share of $-0.70 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.61.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.46 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.61 | $-0.70 |
| 2025-03-18 | 2024-12-31 | $-0.50 | $-0.62 |
| 2024-11-14 | 2024-09-30 | $-0.80 | $-0.50 |
| 2024-08-13 | 2024-06-30 | $-1.00 | $-0.70 |
| 2024-05-14 | 2024-03-31 | $-1.60 | $-1.10 |
| 2024-03-21 | 2023-12-31 | $-1.50 | $-1.60 |
| 2023-11-09 | 2023-09-30 | $-1.80 | $-1.50 |
| 2023-08-10 | 2023-06-30 | $-1.90 | $-1.80 |
| 2023-05-11 | 2023-03-31 | $-2.40 | $-1.70 |
| 2023-03-21 | 2022-12-31 | $-2.10 | $-2.30 |
| 2022-11-03 | 2022-09-30 | $-2.30 | $-1.90 |
| 2022-08-09 | 2022-06-30 | $-2.40 | $-1.80 |
| 2022-05-10 | 2022-03-31 | $-2.10 | $-2.30 |
| 2022-03-18 | 2021-12-31 | $-2.40 | $-1.80 |
| 2021-11-29 | 2021-09-30 | -- | $-5.90 |